Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Menarini’s EMERALD study of ORSERDU in breast cancer shows promising results The Menarini Group and its subsidiary, Stemline Therapeutics, Inc., have made a significant stride in breast cancer treatment… byPallavi MadhirajuDecember 9, 2023